Literature DB >> 22991848

[A case of MRSA infection in multiple artificial joints successfully treated with conservative medical treatment].

Takaaki Nemoto1, Yukitaka Yamasaki, Keito Torikai, Osamu Ishii, Shigeki Fujitani, Takahide Matsuda.   

Abstract

We report herein on a case with multiple MRSA prosthetic arthritis and osteomyelitis successfully treated medically. Our patient was a 64-year-old Japanese woman with a previous medical history of malignant rheumatoid arthritis and multiple surgical interventions with an atlantoaxial fixation in 2003, artificial joint replacement of both knee joints in 2006, and of the right hip joint in September, 2007. She was initially hospitalized due to MRSA arthritis in the right hip in October, 2007. Thereafter, multiple joint infections occurred sequentially in the right knee joint in January 2008 and the left hip joint in June 2008. More recently, the patient was re-admitted in January 2009 due to cervical osteomyelitis with MRSA infection. The patient had been treated with a combination of vancomycin and rifampin for 17 weeks and followed by sulfamethoxazole/trimetoprim in the out-patient setting up to the present. Although the complete resolution of multiple deep MRSA infections with prosthetic arthritis and osteomyelitis is not expected without removing the infectious sources, our patient was successfully treated with chronic antibiotic suppressive therapy. Therefore, we report on our case with a literature review.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22991848     DOI: 10.11150/kansenshogakuzasshi.86.411

Source DB:  PubMed          Journal:  Kansenshogaku Zasshi        ISSN: 0387-5911


  1 in total

1.  Surgical debridement with retention of spinal instrumentation and long-term antimicrobial therapy for multidrug-resistant surgical site infections after spinal surgery: a case series.

Authors:  Shingo Miyazaki; Kenichiro Kakutani; Koichiro Maeno; Toru Takada; Takashi Yurube; Masahiro Kurosaka; Kotaro Nishida
Journal:  Int Orthop       Date:  2015-12-21       Impact factor: 3.075

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.